{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:41:08Z","timestamp":1791232868603,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ahj.2026.107430","type":"journal-article","created":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T16:24:13Z","timestamp":1774110253000},"page":"107430","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Attaining LDL-cholesterol target post major coronary event: Care gap, associated factors and clinical outcomes"],"prefix":"10.1016","volume":"297","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5622-1839","authenticated-orcid":false,"given":"Carlos","family":"Iribarren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan S.","family":"Go","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamal S.","family":"Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karry","family":"Ngai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam M.","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2026.107430_bib0001","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2026.107430_bib0002","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/S0140-6736(14)61368-4","article-title":"Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials","volume":"385","author":"Cholesterol Treatment Trialists","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2026.107430_bib0003","first-page":"e1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2026.107430_bib0004","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2026.107430_bib0005","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006910","article-title":"Effect of PCSK9 inhibitors on clinical outcomes in patients with hypercholesterolemia: a meta-analysis of 35 randomized controlled trials","volume":"6","author":"Karatasakis","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ahj.2026.107430_bib0006","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2026.107430_bib0007","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1186\/s12916-022-02633-5","article-title":"Optimal target of LDL cholesterol level for statin treatment: challenges to monotonic relationship with cardiovascular events","volume":"20","author":"Sakuma","year":"2022","journal-title":"BMC Med"},{"key":"10.1016\/j.ahj.2026.107430_bib0008","unstructured":"https:\/\/www.heart.org\/en\/professional\/quality-improvement\/get-with-the-guidelines, [accessed 15 October 2025]."},{"key":"10.1016\/j.ahj.2026.107430_bib0009","unstructured":"Guideline KP. Atherosclerotic Cardiovascular Disease (ASCVD) Secondary Prevention Guideline. https:\/\/wa.kaiserpermanente.org\/static\/pdf\/public\/guidelines\/ascvd-secondary.pdf, [accessed 15 October 2025]."},{"key":"10.1016\/j.ahj.2026.107430_bib0010","doi-asserted-by":"crossref","first-page":"87","DOI":"10.7812\/TPP\/22.172","article-title":"Comparing Kaiser Permanente members to the general population: implications for generalizability of research","volume":"27","author":"Davis","year":"2023","journal-title":"Perm J"},{"key":"10.1016\/j.ahj.2026.107430_bib0011","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1161\/CIRCOUTCOMES.108.801654","article-title":"The Cardiovascular Research Network: a new paradigm for cardiovascular quality and outcomes research","volume":"1","author":"Go","year":"2008","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.ahj.2026.107430_bib0012","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1586\/14779072.6.8.1043","article-title":"Creating a research data network for cardiovascular disease: the CVRN","volume":"6","author":"Magid","year":"2008","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.ahj.2026.107430_bib0013","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/217047","article-title":"Medication adherence measures: an overview","volume":"2015","author":"Lam","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.ahj.2026.107430_bib0014","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.2337\/diacare.24.7.1144","article-title":"Northern California Kaiser Permanente Diabetes R. Hormone replacement therapy is associated with better glycemic control in women with type 2 diabetes: the Northern California Kaiser Permanente diabetes registry","volume":"24","author":"Ferrara","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ahj.2026.107430_bib0015","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1161\/01.CIR.103.22.2668","article-title":"Glycemic control and heart failure among adult patients with diabetes","volume":"103","author":"Iribarren","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2026.107430_bib0016","doi-asserted-by":"crossref","first-page":"13","DOI":"10.7812\/TPP\/24.028","article-title":"Representativeness of patients with lung cancer in an integrated health care delivery system","volume":"28","author":"Yang","year":"2024","journal-title":"Perm J"},{"key":"10.1016\/j.ahj.2026.107430_bib0017","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.2146\/ajhp040558","article-title":"Number needed to treat: a descriptor for weighing therapeutic options","volume":"62","author":"Wen","year":"2005","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.ahj.2026.107430_bib0018","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1093\/eurheartj\/ehac015","article-title":"Prevalence of statin intolerance: a meta-analysis","volume":"43","author":"Bytyci","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2026.107430_bib0019","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s10557-021-07273-0","article-title":"Challenges in optimizing lipid management in women","volume":"36","author":"Peterson","year":"2022","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.ahj.2026.107430_bib0020","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1471-2261-4-15","article-title":"Disparities in lipid management for African Americans and Caucasians with coronary artery disease: a national cross-sectional study","volume":"4","author":"Massing","year":"2004","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.ahj.2026.107430_bib0021","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0033-3549(04)50262-5","article-title":"Race and trust in the health care system","volume":"118","author":"Boulware","year":"2003","journal-title":"Public Health Rep"},{"key":"10.1016\/j.ahj.2026.107430_bib0022","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1001\/jama.282.6.583","article-title":"Race, gender, and partnership in the patient-physician relationship","volume":"282","author":"Cooper-Patrick","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2026.107430_bib0024","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/j.jacc.2022.02.048","article-title":"High-intensity statin use among patients with atherosclerosis in the U.S","volume":"79","author":"Nelson","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2026.107430_bib0025","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1001\/jamacardio.2021.1810","article-title":"Use of lipid-lowering therapies over 2 years in GOULD, a registry of patients with atherosclerotic cardiovascular disease in the US","volume":"6","author":"Cannon","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ahj.2026.107430_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2022.100336","article-title":"Lipid treatment status and goal attainment among patients with atherosclerotic cardiovascular disease in the United States: A 2019 update","volume":"10","author":"Gu","year":"2022","journal-title":"Am J Prev Cardiol"},{"key":"10.1016\/j.ahj.2026.107430_bib0027","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.amjcard.2022.10.033","article-title":"Bending the cardiovascular event curve by evaluating the potential impact of achieving low-density lipoprotein cholesterol goal across a large health system among secondary prevention patients","volume":"186","author":"Shah","year":"2023","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2026.107430_bib0028","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s40119-025-00397-6","article-title":"Cardiovascular outcomes of early LDL-C goal achievement in patients with very-high-risk ASCVD","volume":"14","author":"Kim","year":"2025","journal-title":"Cardiol Ther"},{"key":"10.1016\/j.ahj.2026.107430_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2023.100472","article-title":"The importance of low-density lipoprotein cholesterol measurement and control as performance measures: A joint clinical perspective from the National Lipid Association and the American Society for Preventive Cardiology","volume":"13","author":"Virani","year":"2023","journal-title":"Am J Prev Cardiol"},{"key":"10.1016\/j.ahj.2026.107430_bib0030","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1016\/j.jacc.2010.09.082","volume":"57","author":"Hsia","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2026.107430_bib0031","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2026.107430_bib0032","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1620\/tjem.255.123","article-title":"Repeated in-stent restenosis despite aggressive lipid loweringby pcsk-9 inhibitor treatment: a case report","volume":"255","author":"Yonezawa","year":"2021","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.ahj.2026.107430_bib0033","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.jacc.2020.07.059","article-title":"Time course of LDL cholesterol exposure and cardiovascular disease event risk","volume":"76","author":"Domanski","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2026.107430_bib0034","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1161\/CIRCULATIONAHA.123.064226","article-title":"Cluster randomized trial of a personalized clinical decision support intervention to improve statin prescribing in patients with atherosclerotic cardiovascular disease","volume":"147","author":"Virani","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2026.107430_bib0035","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1177\/0897190019896505","article-title":"Impact of community pharmacist interventions with managed care to improve medication adherence","volume":"34","author":"Daly","year":"2021","journal-title":"J Pharm Pr"},{"key":"10.1016\/j.ahj.2026.107430_bib0036","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1001\/jamacardio.2022.4018","article-title":"Results of a remotely delivered hypertension and lipid program in more than 10 000 patients across a diverse health care network","volume":"8","author":"Blood","year":"2023","journal-title":"JAMA Cardiol"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000287032600092X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000287032600092X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T04:02:19Z","timestamp":1779249739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000287032600092X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":35,"alternative-id":["S000287032600092X"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2026.107430","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Attaining LDL-cholesterol target post major coronary event: Care gap, associated factors and clinical outcomes","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2026.107430","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107430"}}